Legend Biotech has had a rough stretch in the market, with a steep multi year share price drop sitting alongside growing ...
Outsource pharmaceutical sales to reduce in-house costs, optimize commercialization, support drug launches, and navigate rising regulatory complexity.Dublin, Nov. (GLOBE NEWSWIRE) -- "Pharmaceutical ...
New Jersey-based Legend Biotech announced its Q2 earnings on Monday, reporting $439m of revenues for its only commercial product, the cell therapy Carvykti. Carvykti leads CAR-T therapy sales with ...
PSC Biotech appointed sales agent for APAS Independence across pharmaceutical manufacturing markets in the US, Canada and Singapore Partnership targets regional and mid-tier pharmaceutical ...
Legend Biotech Q3 CARVYKTI sales rise 36% to $710 million, while adjusted net income reaches $55.6 million and management targets 2026 profitability.
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...
In today’s unpredictable global trade environment, with rising tariffs and tensions, investors are looking for stability. That means turning to assets that can hold up under pressure, especially those ...
Ionis Pharmaceuticals lost more than $1 billion in market value on Monday after the company slashed sales projections for a ...
It has been a decent year for the biotech industry so far, buoyed by new drug approvals and positive regulatory/pipeline updates. The third-quarter earnings season has just kicked off, with most major ...
From the intensifying battle over weight-loss drugs to the rise of AI to the uncertainty about President-elect Donald Trump's second term, biotech stocks won't be boring in 2025. Biotech may even be ...
Stock sales from drug developers are off to a flying start on US exchanges in 2026, boosting the prospects for biotechnology fundraising after turbulence in the sector last year. Aided by a rebound in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results